Assessment of intramyocardial hemorrhage with dark-blood T2*-weighted cardiovascular magnetic resonance.
Xingmin GuanYinyin ChenHsin-Jung YangXinheng ZhangDaoyuan RenJane SykesJohn ButlerHui HanMengsu ZengFrank S PratoRohan DharmakumarPublished in: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance (2021)
While IMH can be visible on dark-blood T2*-weighted CMR, the overall conspicuity of IMH is significantly reduced compared to that observed in bright-blood T2*-weighted images, across infarct age in clinical and preclinical settings at 1.5 and 3 T. Hence, bright-blood T2*-weighted CMR would be preferable for clinical use since dark-blood T2*-weighted CMR carries the potential to misclassify hemorrhagic MIs as non-hemorrhagic MIs.